About Modus Outcomes
Modus Outcomes is a Healthcare company based in Cambridge (United States) founded in 2014 by Stefan Cano, and was acquired by THREAD in November 2021. Regulatory support and consulting services are provided for biopharma firms. Modus Outcomes offers products and services including Patient-Centered Outcome Strategy, Instrument Development, Implementation and Use, and Training. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its competitors include Indegene, IntegriChain and ClearView Healthcare Partners; 2 of its 3 listed competitors have raised funding.
Company details
Modus Outcomes was founded in 2014 and is based in Cambridge, United States. Operations focus on the biopharma sector, where regulatory support, business consulting, and related services are delivered. Assistance is extended to companies navigating compliance, strategic planning, and operational needs. The firm, co-founded by Stefan Cano, supports clients in achieving regulatory and business objectives within the industry.
- Headquarters Cambridge, United States
- Founders Stefan Cano
- Stage Acquired
- SectorsHealthcare
- Website modusoutcomes.com
- Social LinkedIn X
- Acquired by THREAD (Nov 2021)
Products & Services of Modus Outcomes
Modus Outcomes offers a comprehensive portfolio of products and services, including Patient-Centered Outcome Strategy, Instrument Development, Implementation and Use, and Training.
Develops strategies for patient outcomes in clinical research.
Creates outcome measures for detecting treatment benefits.
Supports evidence generation for regulatory and market plans.
Offers workshops on patient-centered outcomes and research methods.
Investors in Modus Outcomes
Modus Outcomes has secured backing from 1 investor. Prominent investors backing the company include THREAD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of patient research studies software | 2012 | threadresearch.com | Tustin, United States |
Investor details for Modus Outcomes
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Modus Outcomes
1 people are tracked at Modus Outcomes (1 in leadership).
| Name | Role | Group |
|---|---|---|
Stefan Cano | Co-Founder | Leadership |
Complete people profiles for Modus Outcomes
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Modus Outcomes
2 dated milestones of Modus Outcomes across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Modus Outcomes is founded.
- Exit Acquired by THREAD.
Competitors of Modus Outcomes
Modus Outcomes has 3 listed competitors in our database, 2 of them funded. They include Indegene, IntegriChain and ClearView Healthcare Partners.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clearviewhcp.com | 2008 | Newton, United States | 381 | Strategic consulting services are provided to life sciences companies. |
Detailed competitors of Modus Outcomes
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Modus Outcomes (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Modus Outcomes
Complete news archive for Modus Outcomes
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Modus Outcomes
Modus Outcomes was founded in 2014.
Modus Outcomes is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Modus Outcomes was founded in 2014 and is based in Cambridge, United States. Operations focus on the biopharma sector, where regulatory support, business consulting, and related services are delivered. Assistance is extended to companies navigating compliance, strategic planning, and operational needs. The firm, co-founded by Stefan Cano, supports clients in achieving regulatory and business objectives within the industry.
Modus Outcomes's top competitors include Indegene, IntegriChain and ClearView Healthcare Partners.
Modus Outcomes offers Patient-Centered Outcome Strategy, Instrument Development, Implementation and Use, and Training.
Modus Outcomes has 1 investor. Key investors include THREAD.
Yes. Modus Outcomes was acquired by THREAD in November 2021.